• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology . RTP4 restricts influenza A virus infection by targeting the viral NS1 protein

tetano

Editor, Senior Moderator
Virology


. 2025 Jan 7:603:110397.
doi: 10.1016/j.virol.2025.110397. Online ahead of print. RTP4 restricts influenza A virus infection by targeting the viral NS1 protein

Xueying Lv[SUP] 1 [/SUP], Tian Zheng[SUP] 2 [/SUP], Xiaobo Lei[SUP] 2 [/SUP], Lili Ren[SUP] 2 [/SUP], Shiyi Zhao[SUP] 3 [/SUP], Jingfeng Wang[SUP] 3 [/SUP], Zhou Zhuo[SUP] 4 [/SUP], Jianwei Wang[SUP] 5 [/SUP]



Affiliations
Abstract

The influenza A virus evades the host innate immune response to establish infection by inhibiting RIG-I activation through its nonstructural protein 1 (NS1). Here, we reported that receptor-transporting protein 4 (RTP4), an interferon-stimulated gene (ISG), targets NS1 to inhibit influenza A virus infection. Depletion of RTP4 significantly increased influenza A virus multiplication, while NS1-deficient viruses were unaffected. Mechanistically, RTP4 interacts with NS1 in an RNA-dependent manner and sequesters it from the TRIM25-RIG-I complex, thereby restoring TRIM25-mediated RIG-I K63-linked ubiquitination and subsequent activation of IRF3. Antiviral activity of RTP4 requires the evolutionarily conserved CXXC motifs and an H149 residue in the zinc finger domain, mutations of which disrupted RTP4-NS1 interaction and abrogated the ability of RTP4 to rescue RIG-I-mediated signaling. Collectively, our findings provided insights into the mechanism by which an ISG restricts influenza A virus replication by reactivating host antiviral signaling.

Keywords: Antiviral immunity; Influenza a virus; RTP4; Virus-host interactions.

 
Back
Top